SCHEMBL18855883

SCHEMBL18855883

CONc1cnc2[nH]ccc2c1NC1CCCCC1

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 16/20 0.59
JAK2 O60674 7/20 0.59
HPGDS O60760 1/20 0.49
JAK3 P52333 8/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16477537 0.83 JAK1 (0.60) JAK1JAK2HPGDSJAK3
SCHEMBL15203406 0.81 JAK1 (0.60) JAK1JAK2HPGDSJAK3
SCHEMBL30173286 0.80 JAK1 (0.59) JAK1JAK2HPGDSJAK3
SCHEMBL28608390 0.80 JAK1 (0.59) JAK1JAK2HPGDSJAK3
SCHEMBL18855804 0.79 JAK1 (0.46) JAK1JAK2JAK3
SCHEMBL18855969 0.79 PRKCI (0.41) JAK1JAK2JAK3
SCHEMBL1934804 0.79 JAK2 (0.60) JAK1JAK2HPGDSJAK3
SCHEMBL1717444 0.79 JAK1 (0.60) JAK1JAK2HPGDSJAK3
SCHEMBL2105053 0.79 JAK1 (0.60) JAK1JAK2HPGDSJAK3
SCHEMBL10125409 0.79 JAK1 (0.60) JAK1JAK2HPGDSJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950692-A1 NOVEL TRICYCLIC COMPOUNDS AbbVie Inc. (US) 2022-02-09 EP disclosed
EP-2506716-B1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC (US) 2017-05-17 EP disclosed